Prostaglandin Modulation
Prostaglandin Modulation is a therapeutic strategy within host modulation therapy that selectively regulates the synthesis or activity of prostaglandins to mitigate excessive inflammatory responses and tissue destruction in chronic diseases.
2.3K
Publications
113.2K
Citations
8.4K
Authors
1.6K
Institutions
Publications per year
2017–2026
74
Parents
2.3K
Grazia Maria Spaggiari, Heba Abdelrazik, Flavio Becchetti et al. · Blood · 2009 · 657 citations · Full text
1–5 of 2.3K
8.4K
12
h-index
11
h-index
University of Massachusetts Chan Medical School, United States
11 publications · 1K citations
11
h-index
10
h-index
10
h-index
1–5 of 8.4K
1.6K

Karolinska Institutet
Stockholm, Sweden
30 h-index
113 publications
8.6K citations
University of Michigan
Ann Arbor, United States
24 h-index
118 publications
12.8K citations
Harvard University
Cambridge, United States
21 h-index
73 publications
8.1K citations
UConn Health
Farmington, United States
18 h-index
64 publications
3.9K citations

Kyoto University
Kyoto, Japan
18 h-index
103 publications
3.8K citations
Inserm
Paris, France
18 h-index
76 publications
3.1K citations

Washington University in St. Louis
St Louis, United States
17 h-index
61 publications
4.5K citations

University of Freiburg
Freiburg im Breisgau, Germany
16 h-index
51 publications
2.7K citations
1–8 of 1.6K
Repository · 201 publications · 7.3K citations
45
h-index
142 publications · 5.9K citations
39
h-index
JI · 49 publications · 5.7K citations
35
h-index
BJP · 58 publications · 2.8K citations
34
h-index
JBC · 35 publications · 4.8K citations
32
h-index
1–5